Compare Franklin FTSE South Korea ETF (FLKR) vs Halozyme Therapeutics Inc. Common Stock (HALO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Franklin FTSE South Korea ETF vs Halozyme Therapeutics Inc. Common Stock — how do they compare? Franklin FTSE South Korea ETF trades at $58.4 (market cap $1.83B), while Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 6.9× Franklin FTSE South Korea ETF's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Franklin FTSE South Korea ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Franklin FTSE South Korea ETF for 16 Days and Halozyme Therapeutics Inc. Common Stock for 1 Days on average.
| FLKR | HALO | |
|---|---|---|
Market Cap | $1.83B | $12.58B |
Volume | 679,902 | 2,179,278 |
Sector | Broad Market / Factor | Health |
52-Week High | $72.25 | $115.22 |
52-Week Low | $27.09 | $61.63 |
Typical Hold Time | 16 Days | 1 Days |
Enterprise Value | — | $14.49B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Franklin FTSE South Korea ETF
Franklin FTSE South Korea ETF seeks to track an index of South Korean equities. The fund provides exposure to companies listed in South Korea across multiple sectors.
Read more on FLKR →About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →
